¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Pyruvate Dehydrogenase Complex Deficiency Disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • miner¡¯s disease
    ±¤ºÎº´
  • minimal change disease
    ¹Ì¼¼º¯È­º´
  • malabsorption disease
    Èí¼öÀå¾Öº´
  • mixed connective tissue disease
    È¥ÇÕ°áÇÕÁ¶Á÷º´
  • molecular disease
    ºÐÀÚº´
  • Monge disease
    ¸ùÇ캴
  • motor neuron disease
    ¿îµ¿½Å°æ¼¼Æ÷º´, ¿îµ¿½Å°æ¿øº´
  • mountain disease
    °í»êº´
  • moyamoya disease
    ¸ð¾ß¸ð¾ßº´
  • muscle disease
    ±ÙÀ°º´
  • mycobacterial disease
    Ç×»ê±Õº´, ¹ÌÄÚ¹ÚÅ׸®¾Æº´
  • mycoplasma disease
    ¹ÌÄÚÇö󽺸¶º´
  • maple syrup urine disease
    ´Üdz½Ã·´´¢º´
  • marble bone disease
    ´ë¸®¼®º´, °ñÈ­¼®º´
  • Marburg disease
    ¸¶¸£ºÎ¸£Å©º´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • moyamoya disease
    ¸ð¾ß¸ð¾ßº´
  • muscle disease
    ±ÙÀ°º´
  • mycobacterial disease
    Ç×»ê±Õº´
  • mycoplasma disease
    ¹ÌÄÚÇö󽺸¶º´
  • neoplastic disease
    Á¾¾çº´, ½Å»ý¹°º´
  • nervous disease
    ½Å°æº´
  • neurohypophysial disease
    ½Å°æ³úÇϼöüº´
  • neuromuscular disease
    ½Å°æ±ÙÀ°º´
  • neuronal storage disease
    ½Å°æ¼¼Æ÷ÀúÀ庴
  • neuropathic joint disease
    ½Å°æº´Áõ°üÀýº´
  • notifiable disease
    ½Å°í´ë»óÁúº´
  • nutritional disease
    ¿µ¾çº´
  • obliterative arterial disease
    Æó»öµ¿¸Æº´
  • obstructive pulmonary disease
    Æó¼âÆóº´
  • occlusive cerebrovascular disease
    Æó¼â³úÇ÷°üÁúȯ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • Pompe disease
    ÆûÆäº´
  • Pompes disease
    ÆûÆä¾¾ º´
  • Pott s disease
    Æ÷Æ®º´ ôÃßÄ«¸®¿¡½º .
  • Potts disease
    Æ÷Æ®º´, ôÃßÄ«¸®¿¡½º .
  • Pseudo Hurler disease
    °¡¼ºÇæ·¯º´
  • Raynaud s disease
    ·¹À̳뺴.
  • Refsum s disease
    ·¹ÇÁ¼ûº´.
  • Refsums disease
    ·¹ÇÁ¼û º´
  • Ritter disease
    ¸®ÅÍ º´
  • Rombergs disease = Romberg syndrome
    ·Òº£¸£Å©º´
  • Schilder s disease
    ½Ç´õº´.
  • Sheehans disease
    ½ÃÇѺ´
  • Sj?rens disease
    ¼î±×·»º´, ¼î±×·»ÁõÈıº
  • Stargardts disease=>fundus flavimaculatus
    ½ºÅ¸°¡¸£Æ®º´
  • Stills disease
    ½ºÆ¿ º´
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • mannosidase, alpha-mannosidase, deficiency
    #NAME?
  • mental deficiency
    Áö´É¹Ú¾à(Áõ)(ò±ÒöÚÝå°ñø), Á¤½Å¹Ú¾àÁõ(ïñãêÚÝå°ñø).
  • mental deficiency
    Á¤½Å¹Ú¾à(ïñãêÚÝå°).
  • milk dietary deficiency
    ¿ìÀ¯¿µ¾çÀå¾Ö(¡­ç½å×î¡äô).
  • mineral deficiency
    ¹«±âÁú°áÇÌ(Áõ)(ÙíѦòõÌÀù¹ñø).
  • myeloperoxidase deficiency
    ¸¶¿¡·ÎÆÛ¿Á½Ãµ¥À̽º °áÇÌ(¡­ ÌÀù¹)
  • niacin deficiency
    ³ªÀ̾ƽаáÇÌ
  • niacin, deficiency
    ³ªÀ̾ƽаáÇÌÁõ(¡­ ÌÀù¹ñø)
  • nutrition deficiency
    ¿µ¾ç°áÇÌÁõ.
  • nutritional deficiency
    ¿µ¾ç°áÇÌ(~ÌÀù¹).
  • nutritional deficiency state
    ¿µ¾ç°áÇÌ»óÅ (~ßÒ÷¾).
  • nutritional deficiency syndrome
    ¿µ¾ç°áÇÌÁõÈıº(~ñøý¦ÏØ).
  • organ deficiency
    ±â°üÀÌÁÖ°áÇÌ
  • organ deficiency (cryptorchidism)
    ±â°üÀÌÁÖ°áÇÌ (°íȯÀẹÁõ)
  • organogenetic deficiency
    ±â°ü¹ß»ý°áÇÌ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 19
HSD Hallervorden-Spatz disease; honestly significant difference; hydroxysteroid dehydrogenase; hypertoni...
AAMD American Association on Mental Deficiency; ¹Ì±¹ Á¤½Å ¹Ú¾à Çùȸ
AAMD-ABS American Association on Mental Deficiency-Adaptive Behavior Scale; ¹Ì±¹ Á¤½Å ¹Ú¾à Çùȸ ÀûÀÀ Çൿ ôµµ...
AIDS Acquired Immuno(Immune)-Deficiency Syndrome; ÈÄõ¼º ¸é¿ª °áÇÌ ÁõÈıº
IDA   1) Imino-Diacetic Acid
  2) Iron Deficiency Anemia
   &nb...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 19
CCR Complex chromosome rearrangements
CPS Complex partial seizure
CPSE Complex partial status epilepticus
CS complex spike
COC Cumulus oocyte complex
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Niemann disease
    ´Ï¸¸ÇÈ Áúȯ
    »ýÈÄ ¸î °³¿ùÂë ÇØ¼­ ¹ßº´Çϴµ¥, ½ÉÇÑ °£ºñ Á¾Ã¢, ºÎÁ¾, º¹¼ö, ÇǺÎÀÇ È²»öÁ¶ µîÀÇ Áõ»óÀ» º¼ ¼ö ÀÖ°í, Á¶Á÷ÇÐÀûÀ¸·Î´Â ¸Á³»°è ¼¼Æ÷°¡ ´Ù·®ÀÇ ¸®Æ÷À̵带 ޽ÄÇÏ¿© ´Ï¸¸-ÇÇÅ© ¼¼Æ÷·Î º¯È­ÇØ °£´Ù.
  • Norrie's disease ¸Á¸· ±âÇü¿¡ ÀÇÇÑ ¾çÂÊ ´«ÀÇ ½Ç¸í, Á¤½Å ¹ß´Þ Áö¿¬, ³­Ã»ÀÌ ³ªÅ¸³ª´Â À¯Àü¼º ÁúȯÀ¸·Î¼­ ¹Ý¼º À¯ÀüÀ¸·Î Àü´ÞµÈ´Ù.

    North America

    ºÏ¹Ì
  • notifiable disease
    ½Å°í ´ë»ó º´
    Àü¿°¼º, ÁßÁõµµ ¹× ºóµµ ¶§¹®¿¡ Áß¾Ó, ÁÖ ¶Ç´Â Áö¹æ °üû¿¡ ¹ß»ý º¸°í¸¦ ¿äÇÏ´Â Áúȯ.
  • obliterative arterial disease
    Æó»ö¼º µ¿¸Æ Áúȯ
  • occupational disease
    Á÷¾÷º´
    1. ¾î¶² ƯÁ¤ Á÷¾÷¿¡ Á¾»çÇÔÀ¸·Î½á ±Ù·Î Á¶°ÇÀÌ ¿øÀÎÀÌ µÇ¾î ÀϾ´Â Áúȯ. ±× Á÷¾÷¿¡ Á¾»çÇϰí ÀÖÀ¸¸é ´©±¸µçÁö ÀÌȯµÉ °¡´É¼ºÀÌ ÀÖ´Â Á¡ÀÌ Æ¯»öÀ̸ç, ÀÛ¾÷ ȯ°æÀÇ ºÒºñ³ª ±Ù·Î °úÁßÀÌ °ãÃļ­ ¸¹Àº °æ¿ì¿¡ ¸¸¼ºÀÇ °æ°ú¸¦ °ÅÃÄ ¹ßº´ÇÑ´Ù. Á÷¾÷ ÀÚüÀÇ ¿øÀο¡ ÀÇÇÏ¿© ÀϾ´Â Áúº´¿¡´Â Á÷¾÷º´ ¿Ü¿¡, ÀçÇØ¼º ÁúȯÀÌ ÀÖ´Ù. ÀçÇØ¼º Áúȯµµ Á÷¾÷¿¡ Á¾»çÇϰí ÀÖ´Â ¸ðµç »ç¶÷¿¡°Ô ÀϾÁö¸¸, À¯µ¶ °¡½º³ª °í¿­¹°ÀÇ Æø¹ßÀÌ µ¹¹ßÀûÀ¸·Î ÀϾ´Â °Í°ú °°ÀÌ ¿ì¹ßÀûÀÎ »ç°íÀ̰ųª °ú½ÇÀ̹ǷΠÁ÷¾÷º´°ú´Â ±¸º°ÇÏ¿© »ý°¢Çϰí ÀÖ´Ù. Á÷¾÷º´Àº Á÷Àå Æ¯À¯ÀÇ º´À̱⠶§¹®¿¡ ¹ß»ý ¹æÁö¸¦ À§ÇÏ¿© ±× ¹ß»ý ¿øÀÎÀ» ±Ô¸íÇϰí, ȯ°æÀÇ °³¼± µî¿¡ ¿¹¹æ ´ëÃ¥À» ¼¼¿ìÁö ¾ÊÀ¸¸é ¾È µÈ´Ù. 2. Á÷¾÷¿¡ ¼ö¹ÝÇÏ´Â ÀÎÀÚ¿¡ ÀÇÇÑ Áúȯ, Áï ¿©·¯ °¡Áö ÇüÀÇ ÁøÆóÁõÀ̳ª ÇǺο° µîÀÌ ÀÖ´Ù.
  • Oguchi's disease
    ¿À±¸Ä¡ º´
    ÀϺ»¿¡¼­ ¹ß°ßÇÑ ¼±Ãµ¼º ¾ß¸ÍÁõÀÇ ÇÑ Çü.
  • Owren's disease
    ¿À¿ì·» º´
    ÀÀ°í ÀÎÀÚ VÀÇ °áÇÌ¿¡ ÀÇÇÑ µå¹® ÃâÇ÷¼º ¼ÒÀÎ, »ó¿°»öü ¿­¼º ¼ÒÁú·Î¼­ À¯ÀüµÈ´Ù.
  • Paas' disease
    ÆÄ½º º´
  • Paget's disease
    ÆÄ°Ù º´, ÆÄÁ¬ Áúȯ, ÆÄÁ¦Æ®º´, º¯Çü¼º °ñ¿°, ÆäÀÌÁ¬¾¾ º´
    1. Çϳª³ª ȤÀº ¿©·¯ °ñÀÇ ¿°ÁõÀ» µ¿¹ÝÇÏ´Â ¿øÀÎ ºÒ¸íÀÇ Àå¾Ö·Î¼­ ¹«Á¶Á÷¼º °ñ ȸº¹À» µ¿¹ÝÇÏ´Â °ñÀÇ ºñÈÄ¿Í ¿¬È­¸¦ ÀÏÀ¸Å²´Ù. 2. À¯¹æÀÇ Pagetº´Àº ¸¸¼º ½ÀÁø°ú À¯»çÇÏ°í ¾ÆÆ÷Å©¸°¼±ÀÌ ¸¹Àº ºÎÀ§¿¡ »ý±ä´Ù. Ç×¹® ÁÖÀ§¿¡ »ý±â´Â °Íº¸´Ù´Â ¿ÜÀ½ºÎ¿¡ »ý±â´Â °Í¿¡¼­ µ¿¹ÝµÈ ÇѼ± ¾ÏÀÌ ÀÖÀ» È®·üÀÌ ¸¹´Ù. À¯¹æÀÇ Pagetº´Àº ÀÏÃø¼º ¶Ç´Â µå¹°°Ô ¾çÃø¼ºÀ¸·Î ¿À´Â È«¹Ý¼º Àμ³¼º ÆÇÀ¸·Î Áø¹°ÀÌ ³¯ ¼ö ÀÖÀ¸¸ç ¶§¶§·Î À¯¹æ¾ÏÀÌ µ¿¹ÝµÈ´Ù. 3. °ñÀÇ ÀÌÇü¼º ÁúȯÀ¸·Î 40´ë ÈĹÝ, ³²¼º¿¡ ´õ ¸¹À¸³ª, ¿©¼º¿¡¼­ ´õ ½ÉÇÏ´Ù. ´Ù°ñ¼ºÀ¸·Î »êÀçÇÏ¿© Àå°ñ°ú ôÃß¿¡ ½ÉÇÑ º´º¯À» ¾ß±âÇÏ¿© º¯Çü°ú ºÒ±¸°¡ µÈ´Ù. µÎ°³°ñ°ú »ó¾Ç°ñÀÌ °úµµÇÏ°Ô ¼ºÀåÇϸç, ¶§·Î´Â ÇϾǰñÀÇ °úµµ ¼ºÀåµµ ÀϾ´Ù. 4. ÆÄ°ñ ¼¼Æ÷¿Í °ñ¸ð ¼¼Æ÷ Ȱ¼ºÀÌ Á¶È­¸¦ ÀÌ·çÁö ¸øÇϸ鼭 Å©±â´Â Ä¿ÁöÁö¸¸ ´õ ¾àÇÑ °ñÀ» ¸¸µå´Â ³ªÀÌµç ¼ºÀο¡¼­ ¹ß»ýÇÏ´Â ÁúȯÀ¸·Î µ¿ÅëÀÌ ±¤¹üÀ§ÇÏ°Ô ³ªÅ¸³ª¸ç, Ç÷û ¾ËÄ«¸®¼º Àλê È¿¼Ò¿Í ÇÏÀ̵å·Ï½Ã ÇÁ·Ñ¸°ÀÌ Áõ°¡µÇ°í ¾Ç¼º °ñ Á¾¾çÀ¸·Î ¹ßÀüÇÒ °¡´É¼ºÀÌ ³ô´Ù.
  • pandemic disease
    ¹üÀ¯Ç༺ º´
    ±¤¹üÀ§ÇÏ°Ô ÆÛÁ® ¹ß»ýÇÑ À¯Ç༺ Áúȯ.
  • Parkinsonian disease
    ÆÄŲ½¼¾¾ º´
    1. ¹«¿îµ¿Áõ, ÁøÀü, ±Ù °æÁ÷ÀÌ Æ¯Â¡ÀûÀÎ ½Å°æ Àå¾ÖÀÇ 1±º. 2. Á¤ÁöÇϰí ÀÖÀ» ¶§´Â ÁøÀüÀÌ ³ªÅ¸³ªÁö ¾Ê´Â ÁøÀü ¸¶ºñ.
  • pearl disease
    ÁøÁÖº´
    °¡ÃàÀÇ º¹¸· ¹× Àå°£¸· °áÇÙ.
  • pearl-worker's disease
    ÁøÁÖ°ø º´
    °ñ ºñ´ë¸¦ ¼ö¹ÝÇÏ´Â ¹Ýº¹¼º ¿°ÁõÀ¸·Î¼­, ÁøÁÖ ºÐ¸» ¶Ç´Â ¸ÕÁö°¡ ÀÖ´Â Àå¼Ò¿¡¼­ ÀÏÇÏ´Â »ç¶÷µé¿¡°Ô¼­ º¼ ¼ö ÀÖ´Ù.
  • Pellegrini's disease
    Æç·¹±×¸®´Ï º´
    ¹«¸­ÀÇ ³»º¹ÃøºÎ Àδë À§¿¡¼­ ¹Ý¿ù»ó °ñ Çü¼ºÀ» Ư¡À¸·Î ÇÏ´Â ÁúȯÀ¸·Î¼­ ¿Ü»ó¼º Àü½Å Àå¾Ö°¡ ¿øÀÎÀÌ´Ù.
  • pelvic inflammatory disease
    °ñ¹Ý¿° Áúȯ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
factor xii deficiency A deficiency of a specific blood clotting factor (XII) that may be genetic or acquired. Administration of heparin or severe liver disease may result in factor XII (Hageman factor) deficiency. There are usually no symptoms associated with this deficiency, but there may be symptoms of mild blood loss in some cases. Treatment is generally unnecessary. Individuals should be cautioned against the use of medications (for example aspirin, warfarin, heparin) with anticoagulant activity, due to risk of exaggerated effects.
(27 Sep 1997)
factor xiii deficiency A deficiency of blood coagulation factor xiii or fibrin stabilizing factor (fsf) which enables fibrin to form a firm blood clot. Deficiency of this factor produces a clinical haemorrhagic diathesis.
(12 Dec 1998)
yang deficiency In the yin-yang system of philosophy and medicine, a lack of vital energy (called yangxu in chinese). It manifests itself in various systemic and organic diseases.
(12 Dec 1998)
familial high density lipoprotein deficiency Familial high {density lipoprotein deficiency}; a heritable disorder of lipid metabolism characterised by almost complete absence from plasma of high density lipoproteins, and by storage of cholesterol esters in foam cells, tonsillar enlargement, an orange or yellow-gray colour of the pharyngeal and rectal mucosa, hepatosplenomegaly, lymph node enlargement, corneal opacity, and peripheral neuropathy; autosomal recessive inheritance.
Synonym: familial high {density lipoprotein deficiency}, Tangier disease.
Origin: G. An-, priv., + alpha, a, + lipoprotein + -aemia, blood
(05 Mar 2000)
yin deficiency In the yin-yang system of philosophy and medicine, an insufficiency of body fluid (called yinxu), manifesting often as irritability, thirst, constipation, etc..
(12 Dec 1998)
familial lipoprotein lipase deficiency An rare inherited disorder where there is a deficiency of an enzyme (lipoprotein lipase) which breaks down fat molecules, causing the accumulation of fats or lipoproteins in the blood.
Symptoms in infancy include abdominal pain (appears as if its colic), failure to thrive and skin lesions (xanthomas).
(27 Sep 1997)
zinc deficiency : Deficiency of zinc is associated with short stature, anaemia, increased pigmentation of skin (hyperpigmentation), enlarged liver and spleen (hepatosplenomegaly), impaired gonadal function (hypogonadism), impaired wound healing, and immune deficiency. (for a genetic disorder that impairs zinc uptake, please see acrodermatitis enteropathica). According to the national academy of sciences, the recommended dietary allowances of zinc are 12 milligrams per day for women and 10 milligrams per day for men. Food sources of zinc include meat including liver, eggs, seafood, nuts and cereal.
(12 Dec 1998)
zinc deficiency dermatitis and diarrhoea A genetic disease called acrodermatitis enteropathica is characterised by the simultaneous occurrence of skin inflammation (dermatitis) and diarrhoea. The skin on the cheeks, elbows and knees and tissue about the mouth and anus are inflammed. There is also balding of the scalp, eyebrows and lashes, delayed wound healing and recurrent bacterial and fungal infections due to immune deficiency. The key laboratory finding is an abnormally low blood zinc level reflecting impaired zinc uptake. Oral treatment with zinc is curative.
(12 Dec 1998)
17-hydroxylase deficiency syndrome <syndrome> Congenital deficiency of adrenocortical, and possibly ovarian, steroid C-17a hydroxylase; the resulting excessive secretion of corticosterone and deoxycorticosterone produces hypertension and hypokalaemic alkalosis; absence of aldosterone secretion in such patients may indicate a multiple enzymic deficiency.
(05 Mar 2000)
lactase deficiency An intolerance to milk and dairy products due to a deficiency of lactase in the intestine. Lactase is a enzyme which breaks down milk sugar or lactose. This condition is common in adults and may affect as many as 70-90% of Asians, African Americans, Native Americans and Mediterranean populations. This condition may also develop as the result of an intestinal disease such as celiac sprue.
Symptoms include abdominal cramps, bloating, nausea, weight loss and diarrhoea. Treatment involves removing milk products from the diet. For infant's see Lactofree or ProSobee.
(27 Sep 1997)
folic acid deficiency A nutritional condition produced by a deficiency of folic acid in the diet. Many plant and animal tissues contain folic acid, abundant in green leafy vegetables, yeast, liver, and mushrooms but destroyed by long-term cooking. Alcohol interferes with its intermediate metabolism and absorption. Folic acid deficiency may develop in long-term anticonvulsant therapy or with use of oral contraceptives. This deficiency causes anaemia, macrocytic anaemia, and megaloblastic anaemia. It is indistinguishable from vitamin b 12 deficiency in peripheral blood and bone marrow findings, but the neurologic lesions seen in b 12 deficiency do not occur. (merck manual, 16th ed)
(12 Dec 1998)
folic acid deficiency anaemia Anaemia due to deficiency of folic acid, characterised by large-sized red blood cells (macrocytosis) and presence of large nuclei in erythroid precursor cells (megaloblasts) in the bone marrow.
(05 Mar 2000)
LCAT deficiency A rare condition characterised by corneal opacities, haemolytic anaemia, proteinuria, renal insufficiency, and premature atherosclerosis, and very low levels of lecithin cholesterol acyltransferase (LCAT) activity; results in accumulation of unesterfied cholesterol in plasma and tissues.
(05 Mar 2000)
lecithin acyltransferase deficiency A disease characterised by deficiency or low levels of plasma lecithin cholesterol acyl transferase. Clinical manifestations include corneal opacity, anaemia, and proteinuria.
(12 Dec 1998)
fructose-1,6-diphosphatase deficiency An autosomal recessive fructose metabolism disorder due to absent or deficient fructose-1,6-diphosphatase activity. Gluconeogenesis is impaired, resulting in accumulation of gluconeogenic precursors (e.g., amino acids, lactate, ketones) and manifested as hypoglycaemia, ketosis, and lactic acidosis. Episodes in the newborn infant are often lethal. Later episodes are often brought on by fasting and febrile infections. As patients age through early childhood, tolerance to fasting improves and development becomes normal.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 19
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 19
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 19
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 19
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 19
ÅëÇÕ°Ë»ö ¿Ï·á